Enliven Therapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Royal Bank of Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $749k | 35k | 21.34 |
| 2025-06-30 | $1.3M | 68k | 18.75 |
| 2025-03-31 | $102k | 5.2k | 19.70 |
| 2024-09-30 | $94k | 3.8k | 24.84 |
| 2024-06-30 | $94k | 3.4k | 27.78 |
| 2024-03-31 | $21k | 1.1k | 18.15 |
| 2023-12-31 | $109k | 8.0k | 13.69 |
| 2023-09-30 | $66k | 4.7k | 13.96 |
| 2023-06-30 | $63k | 3.1k | 20.31 |